Nature Biotechnology
2026-06-10 00:00
DOI:
HASH:90a624e6bed489a586f899b294c747ec
Biotech’s coming of age
Authors:
Abstract
Biotech is back. But continued investor caution, the rise of China and fast-moving AI are changing the sector’s contours.